Yesterday, Dec. 31, 2015, 26 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $23.73 to $1,310,562.24.

Highlighted Stocks Traded by Insiders:

Realty Income (O) - FREE Research Report

Case John, who is CEO, President and Director at Realty Income, sold 15,000 shares at $52.01 on Dec. 31, 2015. Following this transaction, the CEO, President and Director owned 218,661 shares meaning that the stake was reduced by 6.42% with the 15,000-share transaction.

The shares most recently traded at $51.63, down $0.38, or 0.74% since the insider transaction. Historical insider transactions for Realty Income go as follows:

  • 4-Week # shares sold: 15,000
  • 12-Week # shares sold: 33,399
  • 24-Week # shares sold: 33,399

The average volume for Realty Income has been 2.2 million shares per day over the past 30 days. Realty Income has a market cap of $13.0 billion and is part of the financial sector and real estate industry. Shares are up 8.82% year-to-date as of the close of trading on Wednesday.

Realty Income Corporation is a publicly traded real estate investment trust. It invests in the real estate markets of the United States. The firm makes investments in commercial real estate. Realty Income Corporation was founded in 1969 and is based in Escondido, California. The stock currently has a dividend yield of 4.39%. The company has a P/E ratio of 47.9. Currently, there are 5 analysts who rate Realty Income a buy, 2 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on O - FREE

TheStreet Quant Ratings

rates Realty Income as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, solid stock price performance and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Realty Income Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Compass Diversified Holdings (CODI) - FREE Research Report

Lazarus Mark H, who is Shareholder at Compass Diversified Holdings, bought 2,408 shares at $15.99 on Dec. 31, 2015. Following this transaction, the Shareholder owned 29,241 shares meaning that the stake was boosted by 8.97% with the 2,408-share transaction.

The shares most recently traded at $15.89, down $0.10, or 0.63% since the insider transaction. Historical insider transactions for Compass Diversified Holdings go as follows:

  • 4-Week # shares bought: 42,408
  • 12-Week # shares bought: 112,241
  • 24-Week # shares bought: 152,121

The average volume for Compass Diversified Holdings has been 120,700 shares per day over the past 30 days. Compass Diversified Holdings has a market cap of $869.9 million and is part of the conglomerates sector and conglomerates industry. Shares are down 2.09% year-to-date as of the close of trading on Wednesday.

Compass Diversified Holdings is a private equity firm specializing in acquisitions, buyouts, and middle market investments. It seeks to invest in manufacturing, distribution, consumer products, and business services sectors. The firm prefers to invest in companies based in North America. The stock currently has a dividend yield of 8.99%. The company has a P/E ratio of 66.8. Currently, there are 5 analysts who rate Compass Diversified Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CODI - FREE

TheStreet Quant Ratings

rates Compass Diversified Holdings as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full

Compass Diversified Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

US Physical Therapy (USPH) - FREE Research Report

Trier Clayton, who is Director at US Physical Therapy, sold 4,500 shares at $55.23 on Dec. 31, 2015. Following this transaction, the Director owned 11,250 shares meaning that the stake was reduced by 28.57% with the 4,500-share transaction.

The shares most recently traded at $53.68, down $1.55, or 2.89% since the insider transaction. Historical insider transactions for US Physical Therapy go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 8,500
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 41,799
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 58,397

The average volume for US Physical Therapy has been 118,000 shares per day over the past 30 days. US Physical Therapy has a market cap of $687.0 million and is part of the health care sector and health services industry. Shares are up 30.79% year-to-date as of the close of trading on Wednesday.

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics in the United States. The stock currently has a dividend yield of 1.08%. The company has a P/E ratio of 32.0. Currently, there are 2 analysts who rate US Physical Therapy a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on USPH - FREE

TheStreet Quant Ratings

rates US Physical Therapy as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

US Physical Therapy Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.